nanovaccine

toll-like receptor 7 ; Mus musculus







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35007785 Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy. 2022 Mar 15 5
2 35302770 A pH-/Enzyme-Responsive Nanoparticle Selectively Targets Endosomal Toll-like Receptors to Potentiate Robust Cancer Vaccination. 2022 Apr 13 2
3 34452929 Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response. 2021 Aug 2
4 30620878 Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based Nanovaccine. 2019 Mar 4 1